Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Jiangsu Aoyang Health Industry Co.ltd.
  6. News
  7. Summary
    002172   CNE1000006Y7

JIANGSU AOYANG HEALTH INDUSTRY CO.LTD.

(002172)
  Report
SummaryChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

China stocks end higher as healthcare gains on three-child policy

06/01/2021 | 03:25am EST

SHANGHAI, June 1 (Reuters) - China stocks eked out gains on Tuesday, helped by strength in healthcare firms, as investors cheered Beijing's latest three-child policy after recent data showed a dramatic decline in births in the world's most populous country.

** The blue-chip CSI300 index was up 0.2% at 5,341.68, while the Shanghai Composite Index added 0.3% to 3,624.71.

** Shenzhen's start-up board ChiNext slipped 0.3%, while Shanghai's tech-focused STAR50 index firmed 1.2%.

** Leading the gains, the CSI300 healthcare index climbed 1.7%.

** Birth- and fertility-related companies advanced as investors continued to cheer Beijing's major policy support.

** Married Chinese couples may have up to three children, China announced on Monday. Beijing had scrapped its decades-old one-child policy in 2016, replacing it with a two-child limit to try and stave off risks to its economy from a rapidly aging population.

** Jiangsu Aoyang Health Industry Co Ltd, Shanghai Aiyingshi, Beingmate Co Ltd, Changchun High & New Technology Industries Group Inc and Goldlok Holdings Guangdong Co Ltd climbed between 5.2% and 10%.

** But analysts and traders expected limited impact from the policy shift on the market as a whole.

** "The three-child policy could have an impact on China's long-term economic growth, while its stimulus could be limited for those who already have two children," Luo Kun, an investment manager at Chasing Securities' equities investment arm, said.

** Luo said he did not see a major impact on the stock market, noting gains for related companies could mainly be a result of short-term speculation.

** China's market regulator fined 15 private tutoring firms a combined 36.5 million yuan ($5.73 million) for false advertising and pricing frauds, the official People's Daily newspaper reported on Tuesday, amid a crackdown on the sector. (Reporting by Shanghai Newsroom, Editing by Sherry Jacob-Phillips)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
BEINGMATE CO., LTD. -0.41% 4.83 End-of-day quote.-22.35%
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC. 3.42% 289.99 End-of-day quote.-35.40%
GOLDLOK HOLDINGS(GUANGDONG) CO.,LTD. 0.00% 2.02 End-of-day quote.-3.35%
JIANGSU AOYANG HEALTH INDUSTRY CO.LTD. 0.26% 3.84 End-of-day quote.28.43%
S&P/CITIC 300 INDEX 0.00% 4470.26 Delayed Quote.-3.57%
S&P/CITIC 50 INDEX 0.00% 4169.6 Delayed Quote.-11.30%
SHANGHAI AIYINGSHI CO.,LTD 0.90% 21.2 End-of-day quote.-7.59%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) -0.01% 6.3703 Delayed Quote.-1.91%
All news about JIANGSU AOYANG HEALTH INDUSTRY CO.LTD.
10/28Jiangsu Aoyang Health Industry Co.ltd. Reports Earnings Results for the Nine Months End..
CI
09/27Jiangsu Aoyang Health Industry Co.ltd. cancelled the transaction announced on July 14, ..
CI
08/30Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the Half Year Ended..
CI
07/14Jiangsu Aoyang Health Industry Co.ltd. announced that it expects to receive CNY 300 mil..
CI
06/01China stocks end higher as healthcare gains on three-child policy
RE
04/27Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the First Quarter E..
CI
03/19Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the Full Year Ended..
CI
2020Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the Nine Months End..
CI
2020Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the Half Year Ended..
CI
2020Jiangsu Aoyang Health Industry Co.Ltd. Reports Earnings Results for the First Quarter E..
CI
More news
Financials
Sales 2020 3 083 M 484 M 484 M
Net income 2020 -459 M -72,0 M -72,0 M
Net Debt 2020 1 279 M 201 M 201 M
P/E ratio 2020 -5,07x
Yield 2020 -
Capitalization 2 940 M 461 M 461 M
EV / Sales 2019 1,71x
EV / Sales 2020 1,16x
Nbr of Employees 3 742
Free-Float 61,0%
Chart JIANGSU AOYANG HEALTH INDUSTRY CO.LTD.
Duration : Period :
Jiangsu Aoyang Health Industry Co.ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU AOYANG HEALTH INDUSTRY CO.LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 3,84 CNY
Average target price 5,10 CNY
Spread / Average Target 32,8%
Managers and Directors
Xue Ru Shen Chairman & General Manager
Yi Bing Yuan Chief Financial Officer & Director
Li Ying Xu Chairman-Supervisory Board
Xu Chao Independent Director
Xian Feng Chen Independent Director